IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections to deliver powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 70,000 employees, IQVIA conducts operations in more than 100 countries. Learn more at www.iqvia.com.
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.
Total Clinical Trial Management (TCTM) is a full service CRO created on the founding principle that relationships between research sites and the CRO is a critical element in ensuring successful study completion. TCTM’s proprietary TotalTouch Site Advantage process has proven to dramatically increase study timelines and deliver results.
Areas of focus include pain, orthopedic injury, dermatology and generic and OTC studies. TCTM boasts an in-house patient recruitment team with a track record of successful enrollment strategy and tactical planning.
Covance, the drug development business of Laboratory Corporation of America® Holdings (LabCorp®), is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real®.
Whether your priority is networking with sponsors and CRO attendees or learning best practices built for research sites, the Summit will provide a unique experience for your business.
For the last 16 years, the Global Site Solutions Summit has been committed to being “the site’s meeting.” The Summit provides a unique hub where sites, sponsors, CRO executives and regulators come together and share best practices, build their businesses, and develop new partnerships through debates, ideation sessions, workshops and focus groups.
SCRS is confident that by increasing site sustainability, all life science stakeholders will realize greater efficiency and profitability, and successfully meet our ultimate commitment to bring safe medical treatments to patients faster. The Global Summit will deliver the high-quality education, training, and best practices that attendees have come to expect.
Over the past 27 years, PAREXEL has developed significant expertise to assist clients in the worldwide pharmaceutical, biotechnology and medical device industries with the development and launch of their products in order to bring safe and effective treatments to the global marketplace for the patients who need them. Headquartered near Boston, Massachusetts, PAREXEL operates in 67 locations throughout 52 countries around the world, and has approximately 10,850 employees.
We are a leading global bio/pharmaceutical services organization that helps clients expedite time-to-market through our development and launch services. These include a broad range of clinical development capabilities, integrated advanced technologies, regulatory affairs consulting, and commercialization services.
